NYSE:VSI - Vitamin Shoppe Stock Price, Price Target & More

Vitamin Shoppe trades on the New York Stock Exchange (NYSE) under the ticker symbol "VSI."

Vitamin Shoppe Inc (NYSE:VSI) released its quarterly earnings data on Wednesday, May, 9th. The specialty retailer reported $0.10 earnings per share for the quarter, meeting the consensus estimate of $0.10. The specialty retailer had revenue of $295.96 million for the quarter, compared to analyst estimates of $293.44 million. Vitamin Shoppe had a positive return on equity of 1.28% and a negative net margin of 22.80%. View Vitamin Shoppe's Earnings History.

Vitamin Shoppe is scheduled to release their next quarterly earnings announcement on Tuesday, August, 7th 2018. View Earnings Estimates for Vitamin Shoppe.

5 brokerages have issued 12 month target prices for Vitamin Shoppe's stock. Their forecasts range from $3.00 to $7.00. On average, they expect Vitamin Shoppe's share price to reach $4.95 in the next year. View Analyst Ratings for Vitamin Shoppe.

Some companies that are related to Vitamin Shoppe include J Sainsbury (JSAIY), CECONOMY AG/ADR (MTTRY), GNC (GNC), DavidsTea (DTEA), Green Polkadot Box (GPDB) and Crumbs Bake Shop (CRMBQ).

Headlines about VSI stock have trended positive recently, Accern Sentiment reports. The research firm scores the sentiment of press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Vitamin Shoppe earned a daily sentiment score of 0.25 on Accern's scale. They also assigned media coverage about the specialty retailer an impact score of 47.24 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

Vitamin Shoppe's stock is owned by many different of retail and institutional investors. Top institutional investors include SHAH CAPITAL MANAGEMENT (17.70%), VINTAGE CAPITAL MANAGEMENT LLC (17.70%), VINTAGE CAPITAL MANAGEMENT LLC (14.80%), BlackRock Inc. (12.50%), Dimensional Fund Advisors LP (6.92%) and Tamarack Advisers LP (4.63%). Company insiders that own Vitamin Shoppe stock include Alex Smith, B Michael Becker, Dan Lamadrid, Guillermo Marmol, John D Bowlin, Richard L Markee, Shah Capital Management and Vintage Capital Management Llc. View Institutional Ownership Trends for Vitamin Shoppe.

VSI stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Landscape Capital Management L.L.C., OppenheimerFunds Inc., Guggenheim Capital LLC and Prudential Financial Inc.. View Insider Buying and Selling for Vitamin Shoppe.

VSI stock was acquired by a variety of institutional investors in the last quarter, including Tamarack Advisers LP, Millennium Management LLC, Schwab Charles Investment Management Inc., Dimensional Fund Advisors LP, GSA Capital Partners LLP and California Public Employees Retirement System. Company insiders that have bought Vitamin Shoppe stock in the last two years include Alex Smith, Guillermo Marmol, John D Bowlin, Shah Capital Management and Vintage Capital Management Llc. View Insider Buying and Selling for Vitamin Shoppe.

Shares of VSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of VSI stock can currently be purchased for approximately $7.55.

Vitamin Shoppe has a market capitalization of $190.22 million and generates $1.18 billion in revenue each year. The specialty retailer earns $-252,150,000.00 in net income (profit) each year or $0.39 on an earnings per share basis. Vitamin Shoppe employs 5,573 workers across the globe.

Vitamin Shoppe's mailing address is 300 HARMON MEADOW BLVD., SECAUCUS NJ, 07094. The specialty retailer can be reached via phone at 201-868-5959 or via email at [email protected]